세계의 비타민 K2 시장 예측(-2029년) : 기능별, 제품 유형별, 적용 형태별, 유래별, 용도별, 지역별

The global vitamin K2 market is estimated to be valued at USD 140 million in 2024 and is projected to reach USD 265 million by 2029 at a CAGR of 13.7%. The growth of the Vitamin K2 market is propelled by advancements in research and development. Ongoing studies continue to uncover new health benefits and potential applications for Vitamin K2, thereby expanding its appeal. These emerging benefits contribute to a broader consumer base and create new opportunities for product innovation in the nutraceutical and functional food sectors.

Furthermore, market growth is facilitated by increasing consumer awareness and education. Campaigns and informational resources provided by health organizations and supplement manufacturers have significantly raised awareness about the importance of Vitamin K2. This has led to higher consumer confidence and an uptick in the consumption of Vitamin K2-enriched products. Additionally, the trend towards personalized nutrition, where consumers seek tailored dietary solutions to meet their specific health needs, has spurred demand for Vitamin K2 supplements.

"During the forecast period, the health supplements segment in applications emerges as the dominant segment in the vitamin K2 market."

This trend is largely driven by the increasing consumer inclination towards preventive healthcare and wellness. As individuals become more aware of the long-term benefits of maintaining bone and cardiovascular health, the demand for effective and reliable supplements has surged. Vitamin K2, known for its crucial role in calcium metabolism and cardiovascular protection, is gaining significant traction among health-conscious consumers.

One of the primary reasons for the dominance of the health supplements segment is the growing body of scientific evidence supporting the efficacy of Vitamin K2. Numerous studies have highlighted its role in promoting bone density and preventing arterial calcification, thereby reducing the risk of osteoporosis and cardiovascular diseases. These benefits are particularly appealing to aging populations, who are more susceptible to these conditions. As a result, Vitamin K2 supplements have become a popular choice among older adults looking to enhance their health and quality of life.

"Powder & Crystalline form is the dominant market in the vitamin K2 market."

The powder & crystalline form of Vitamin K2 is emerging as the dominant segment in the Vitamin K2 market, driven by its versatile applications and numerous advantages over other forms. This trend reflects a growing preference for powdered supplements in both the consumer and industrial markets, underscoring the convenience, stability, and efficacy that powdered Vitamin K2 offers.

The factor contributing to the dominance of the powder form in the Vitamin K2 market is its exceptional versatility. Vitamin K2 powder can be easily incorporated into a wide range of products, including dietary supplements, functional foods, and beverages. This adaptability allows manufacturers to create a diverse array of Vitamin K2-enriched products, catering to various consumer preferences and dietary needs. For example, powdered Vitamin K2 can be seamlessly blended into protein shakes, nutritional bars, dairy products, and even baked goods, making it a suitable choice for both health enthusiasts and the general population.

The break-up of the profile of primary participants in the vitamin K2 market:

• By Company Type: Tier 1 - 35%, Tier 2 - 30%, and Tier 3 - 35%
• By Designation: C Level - 22%, Director Level - 33%, Others - 45%
• By Region: North America - 17%, Europe - 26%, Asia Pacific - 38%, and Rest of the World - 19%

Prominent companies include Gnosis by Lesaffre (NattoPharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-OIL MILLS INC. (Japan), Novozymes A/S (Denmark), BASF SE (Germany), Sungen Bioscience Co.,Ltd. (China), Vesta Nutra (US), Richen Nutritional Technology Co., Ltd. (China), Menadiona (Spain), and GENOFOCUS (Korea) among others.

Research Coverage:

This research report categorizes the vitamin K2 market by Product Type (MK-4, MK-7), Source (Natural, Synthetic), Form (Capsules & Tablets, Powder & Crystalline, Oils & Liquid), Application (Pharmaceuticals, Functional Food & Beverages, Health Supplements), and Region (North America, Europe, Asia Pacific, and Rest of the World).

The report covers information about the key factors, such as drivers, restraints, opportunities, and challenges impacting the growth of the vitamin K2 market. It also provides a detailed analysis of the major players in the market, including their business overview, products offered, key strategies, partnerships, new product launches, expansions, and acquisitions. Competitive benchmarking of upcoming startups in the vitamin K2 market is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall vitamin K2 market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (Growth in health consciousness among consumers and increasing health expenditure, and Increase in research and application of vitamin K2), restraints (Inconsistency in regulatory norms governing vitamin K2, and Price volatility of raw materials), opportunities (Growing demand for natural and functional foods, Demand for personalized nutrition and tailored menaquinone products, and Untapped vitamin K2 applications), and challenges (Lack of consumer awareness regarding benefits specific to vitamin K2, and High research and development costs) influencing the growth of the vitamin K2 market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the vitamin K2 market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the vitamin K2 market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vitamin K2 market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Gnosis by Lesaffre (NattoPharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-OIL MILLS INC. (Japan), Novozymes A/S (Denmark), BASF SE (Germany), Sungen Bioscience Co.,Ltd. (China), Vesta Nutra (US), Richen Nutritional Technology Co., Ltd. (China), Menadiona (Spain), and GENOFOCUS (Korea), among others in the vitamin K2 market strategies. The report also helps stakeholders understand the vitamin K2 market and provides them with information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 REGIONS COVERED
  • 1.3.3 YEARS CONSIDERED
• 1.4 UNIT CONSIDERED
  • 1.4.1 CURRENCY UNIT
  • 1.4.2 VOLUME UNIT
• 1.5 STAKEHOLDERS
• 1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key insights from industry experts
    • 2.1.2.3 Breakdown of primaries
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 TOP-DOWN APPROACH
  • 2.2.2 SUPPLY-SIDE ANALYSIS
  • 2.2.3 BOTTOM-UP APPROACH
• 2.3 DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
• 2.5 LIMITATIONS AND RISK ASSESSMENT
• 2.6 RECESSION IMPACT ANALYSIS
  • 2.6.1 RECESSION MACROINDICATORS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN VITAMIN K2 MARKET
• 4.2 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE AND KEY COUNTRY
• 4.3 VITAMIN K2 MARKET: SHARE OF MAJOR REGIONAL SUBMARKETS
• 4.4 VITAMIN K2 MARKET, BY PRODUCT TYPE AND REGION
• 4.5 VITAMIN K2 MARKET, BY APPLICATION FORM
• 4.6 VITAMIN K2 MARKET, BY SOURCE
• 4.7 VITAMIN K2 MARKET, BY APPLICATION

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MACROECONOMIC INDICATORS
  • 5.2.1 RISING GDP AND POPULATION
  • 5.2.2 RISE IN HEALTH CONCERNS AND DISEASE INCIDENCES
  • 5.2.3 INCREASE IN HEALTHCARE EXPENDITURE AND PREVENTIVE HEALTHCARE TRENDS
• 5.3 MARKET DYNAMICS
  • 5.3.1 DRIVERS
    • 5.3.1.1 Rising health consciousness among consumers
    • 5.3.1.2 Growing research and development activities
  • 5.3.2 RESTRAINTS
    • 5.3.2.1 Inconsistency in regulatory norms
    • 5.3.2.2 Price volatility of raw materials
  • 5.3.3 OPPORTUNITIES
    • 5.3.3.1 Growing demand for natural and plant-based ingredients
    • 5.3.3.2 Rising need for personalized nutrition and customized products
    • 5.3.3.3 Untapped applications
  • 5.3.4 CHALLENGES
    • 5.3.4.1 Lack of consumer awareness regarding specific health benefits of Vitamin K2
    • 5.3.4.2 High research and development costs

6 INDUSTRY TRENDS

• 6.1 INTRODUCTION
• 6.2 SUPPLY CHAIN ANALYSIS
• 6.3 VALUE CHAIN ANALYSIS
  • 6.3.1 RAW MATERIAL SOURCING
  • 6.3.2 MANUFACTURING AND PROCESSING
  • 6.3.3 PRODUCT FORMULATION AND DEVELOPMENT
  • 6.3.4 QUALITY ASSURANCE AND CERTIFICATION
  • 6.3.5 MARKETING AND DISTRIBUTION
• 6.4 TRADE ANALYSIS
  • 6.4.1 EXPORT SCENARIO
  • 6.4.2 IMPORT SCENARIO
  • 6.4.3 HS CODE FOR VITAMIN K2 WITH PRODUCT DESCRIPTION
• 6.5 TECHNOLOGY ANALYSIS
  • 6.5.1 KEY TECHNOLOGY
    • 6.5.1.1 Fermentation technology
  • 6.5.2 COMPLEMENTARY TECHNOLOGY
    • 6.5.2.1 Encapsulation technology
  • 6.5.3 ADJACENT TECHNOLOGY
    • 6.5.3.1 Biotechnology
• 6.6 PRICING ANALYSIS
  • 6.6.1 AVERAGE SELLING PRICE TREND BY PRODUCT TYPE
  • 6.6.2 AVERAGE SELLING PRICE TREND, BY REGION
• 6.7 ECOSYSTEM ANALYSIS
  • 6.7.1 DEMAND SIDE
  • 6.7.2 SUPPLY SIDE
• 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 6.9 PATENT ANALYSIS
  • 6.9.1 LIST OF MAJOR PATENTS
• 6.10 KEY CONFERENCES AND EVENTS, 2024-2025
• 6.11 REGULATORY LANDSCAPE
  • 6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 6.11.1.1 Regulations in North America
      • 6.11.1.1.1 US
      • 6.11.1.1.2 Canada
    • 6.11.1.2 Regulations in Europe
    • 6.11.1.3 Regulations in Asia Pacific
      • 6.11.1.3.1 China
      • 6.11.1.3.2 India
• 6.12 PORTER'S FIVE FORCES ANALYSIS
  • 6.12.1 INTENSITY OF COMPETITIVE RIVALRY
  • 6.12.2 BARGAINING POWER OF SUPPLIERS
  • 6.12.3 BARGAINING POWER OF BUYERS
  • 6.12.4 THREAT OF NEW ENTRANTS
  • 6.12.5 THREAT OF SUBSTITUTES
• 6.13 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 6.13.2 BUYING CRITERIA
• 6.14 CASE STUDY ANALYSIS
  • 6.14.1 ESTABLISHING DISTINCT RECOMMENDED DIETARY INTAKE TO PROMOTE HEALTHIER DIETARY CHOICES
  • 6.14.2 ENHANCING ABILITY IN NUTRACEUTICAL FORMULATIONS FOR IMPROVED QUALITY AND EFFICACY
• 6.15 INVESTMENT AND FUNDING SCENARIO

7 VITAMIN K2 MARKET, BY FUNCTION

• 7.1 INTRODUCTION
• 7.2 BONE AND CARDIOVASCULAR HEALTH
  • 7.2.1 COMPREHENSIVE HEALTH BENEFITS TO DRIVE MARKET
• 7.3 BLOOD HEALTH AND CLOTTING
  • 7.3.1 EFFICACY IN MANAGING CLOTTING DISORDERS TO BOOST MARKET GROWTH
• 7.4 ANTI-INFLAMMATORY AND IMMUNITY
  • 7.4.1 THERAPEUTIC POTENTIAL AND IMMUNITY-SUPPORTING PROPERTIES TO SUPPORT MARKET GROWTH
• 7.5 OTHER FUNCTIONS

8 VITAMIN K2 MARKET, BY PRODUCT TYPE

• 8.1 INTRODUCTION
• 8.2 MK-7
  • 8.2.1 HIGH BIOAVAILABILITY TO PROPEL MARKET GROWTH
• 8.3 MK-4
  • 8.3.1 POTENTIAL BENEFITS IN BONE AND CARDIOVASCULAR HEALTH TO DRIVE MARKET GROWTH

9 VITAMIN K2 MARKET, BY APPLICATION FORM

• 9.1 INTRODUCTION
• 9.2 CAPSULES AND TABLETS
  • 9.2.1 ABILITY TO CATER TO DIVERSE CONSUMER NEEDS AND PREFERENCES TO DRIVE MARKET
• 9.3 POWDER AND CRYSTALLINE
  • 9.3.1 SURGING DEMAND FOR CUSTOMIZABLE DOSAGES AND HIGH PURITY TO PROPEL MARKET GROWTH
• 9.4 LIQUIDS
  • 9.4.1 GROWING NEED FOR SUPPLEMENTS WITH ENHANCED BIOAVAILABILITY TO BOOST SEGMENT GROWTH

10 VITAMIN K2 MARKET, BY SOURCE

• 10.1 INTRODUCTION
• 10.2 NATURAL ORIGIN
  • 10.2.1 INCREASING CONSUMER PREFERENCE FOR NON-GMO SUPPLEMENTS TO BOOST MARKET GROWTH
• 10.3 SYNTHETIC ORIGIN
  • 10.3.1 LOW PRODUCTION COST TO DRIVE MARKET

11 VITAMIN K2 MARKET, BY APPLICATION

• 11.1 INTRODUCTION
• 11.2 HEALTH SUPPLEMENTS
  • 11.2.1 INCREASED AWARENESS REGARDING ASSOCIATED HEALTH BENEFITS TO DRIVE MARKET
• 11.3 FUNCTIONAL FOODS AND BEVERAGES
  • 11.3.1 GROWING DEMAND FOR FORTIFIED FUNCTIONAL FOODS TO PROPEL MARKET GROWTH
• 11.4 PHARMACEUTICALS
  • 11.4.1 RISING GOVERNMENT INVESTMENTS IN DEVELOPMENT OF NEW FORMULATIONS TO DRIVE MARKET

12 VITAMIN K2 MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
  • 12.2.2 US
    • 12.2.2.1 Growing awareness regarding importance of preventive health measures to drive market
  • 12.2.3 CANADA
    • 12.2.3.1 Increasing focus on preventive healthcare and natural products to propel market
  • 12.2.4 MEXICO
    • 12.2.4.1 High prevalence of chronic lifestyle diseases to drive market
• 12.3 EUROPE
  • 12.3.1 EUROPE: RECESSION IMPACT ANALYSIS
  • 12.3.2 GERMANY
    • 12.3.2.1 Rising focus on proactive healthcare to drive market
  • 12.3.3 FRANCE
    • 12.3.3.1 Innovative products and investments in research and development to boost market growth
  • 12.3.4 UK
    • 12.3.4.1 Rapidly aging population to propel market growth
  • 12.3.5 ITALY
    • 12.3.5.1 Evolving dietary preferences to boost market growth
  • 12.3.6 SPAIN
    • 12.3.6.1 Growing consumer interest in health supplements to propel drive demand
  • 12.3.7 REST OF EUROPE
• 12.4 ASIA PACIFIC
  • 12.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
  • 12.4.2 CHINA
    • 12.4.2.1 Surging use of digital media to disseminate healthcare information to propel market
  • 12.4.3 JAPAN
    • 12.4.3.1 Consumer preferences for natural healthcare solutions to boost market growth
  • 12.4.4 INDIA
    • 12.4.4.1 Strategic market penetration initiatives by various companies to drive market
  • 12.4.5 AUSTRALIA AND NEW ZEALAND
    • 12.4.5.1 Changing consumer preferences and increasing health consciousness to drive demand
  • 12.4.6 REST OF ASIA PACIFIC
• 12.5 ROW
  • 12.5.1 ROW: RECESSION IMPACT ANALYSIS
  • 12.5.2 SOUTH AMERICA
    • 12.5.2.1 Collaboration among key market players to drive market growth
  • 12.5.3 MIDDLE EAST AND AFRICA
    • 12.5.3.1 Developing regulatory landscape to propel market growth

13 COMPETITIVE LANDSCAPE

• 13.1 OVERVIEW
• 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
• 13.3 MARKET SHARE ANALYSIS
• 13.4 COMPANY VALUATION AND FINANCIAL METRICS
  • 13.4.1 COMPANY VALUATION
  • 13.4.2 EV/EBITDA
• 13.5 BRAND/PRODUCT COMPARISON ANALYSIS
• 13.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 13.6.1 STARS
  • 13.6.2 EMERGING LEADERS
  • 13.6.3 PERVASIVE PLAYERS
  • 13.6.4 PARTICIPANTS
  • 13.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 13.6.5.1 Company footprint
    • 13.6.5.2 Regional footprint
    • 13.6.5.3 Product type footprint
    • 13.6.5.4 Application footprint
• 13.7 COMPANY EVALUATION MATRIX: DISTRIBUTORS/SUPPLIERS
  • 13.7.1 PROGRESSIVE COMPANIES
  • 13.7.2 RESPONSIVE COMPANIES
  • 13.7.3 DYNAMIC COMPANIES
  • 13.7.4 STARTING BLOCKS
  • 13.7.5 COMPETITIVE BENCHMARKING
    • 13.7.5.1 Detailed list of key distributors/suppliers
    • 13.7.5.2 Competitive benchmarking of key distributors/suppliers
• 13.8 COMPETITIVE SCENARIO AND TRENDS
  • 13.8.1 PRODUCT LAUNCHES AND DEVELOPMENTS
  • 13.8.2 DEALS
  • 13.8.3 EXPANSIONS
  • 13.8.4 OTHERS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS (MANUFACTURERS)
  • 14.1.1 GNOSIS BY LESAFFRE (NATTOPHARMA)
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products/Solutions/Services offered
    • 14.1.1.3 Recent developments
    • 14.1.1.4 MnM view
      • 14.1.1.4.1 Right to win
      • 14.1.1.4.2 Strategic choices
      • 14.1.1.4.3 Weaknesses and competitive threats
  • 14.1.2 KAPPA BIOSCIENCE AS (BALCHEM CORP.)
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products/Solutions/Services offered
    • 14.1.2.3 Recent developments
    • 14.1.2.4 MnM view
      • 14.1.2.4.1 Right to win
      • 14.1.2.4.2 Strategic choices
      • 14.1.2.4.3 Weaknesses and competitive threats
  • 14.1.3 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.) (PLT HEALTH SOLUTIONS, INC.) (JAPAN)
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products/Solutions/Services offered
    • 14.1.3.3 Recent developments
    • 14.1.3.4 MnM view
      • 14.1.3.4.1 Right to win
      • 14.1.3.4.2 Strategic choices
      • 14.1.3.4.3 Weaknesses and competitive threats
  • 14.1.4 NOVOZYMES A/S, PART OF NOVONESIS GROUP
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products/Solutions/Services offered
    • 14.1.4.3 Recent developments
    • 14.1.4.4 MnM view
      • 14.1.4.4.1 Right to win
      • 14.1.4.4.2 Strategic choices
      • 14.1.4.4.3 Weaknesses and competitive threats
  • 14.1.5 SUNGEN BIOSCIENCE CO., LTD
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products/Solutions/Services offered
    • 14.1.5.3 Recent developments
    • 14.1.5.4 MnM view
  • 14.1.6 VESTA NUTRA
    • 14.1.6.1 Business overview
    • 14.1.6.2 Products/Solutions/Services offered
    • 14.1.6.3 Recent developments
    • 14.1.6.4 MnM view
  • 14.1.7 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.
    • 14.1.7.1 Business overview
    • 14.1.7.2 Products/Solutions/Services offered
    • 14.1.7.3 Recent developments
    • 14.1.7.4 MnM view
  • 14.1.8 MENADIONA
    • 14.1.8.1 Business overview
    • 14.1.8.2 Products/Solutions/Services offered
    • 14.1.8.3 Recent developments
    • 14.1.8.4 MnM view
  • 14.1.9 GF FERMENTECH (GENOFOCUS)
    • 14.1.9.1 Business overview
    • 14.1.9.2 Products/Solutions/Services offered
    • 14.1.9.3 Recent developments
    • 14.1.9.4 MnM view
  • 14.1.10 ANGELYEAST CO., LTD.
    • 14.1.10.1 Business overview
    • 14.1.10.2 Products/Solutions/Services offered
    • 14.1.10.3 Recent developments
    • 14.1.10.4 MnM view
  • 14.1.11 GENEFERM BIOTECHNOLOGY CO., LTD.
    • 14.1.11.1 Business overview
    • 14.1.11.2 Products/Solutions/Services offered
    • 14.1.11.3 Recent developments
    • 14.1.11.4 MnM view
  • 14.1.12 NAKODA CHEMICALS LTD.
    • 14.1.12.1 Business overview
    • 14.1.12.2 Products/Solutions/Services offered
    • 14.1.12.3 Recent developments
    • 14.1.12.4 MnM view
  • 14.1.13 HAIHANG INDUSTRY CO., LTD.
    • 14.1.13.1 Business overview
    • 14.1.13.2 Products/Solutions/Services offered
    • 14.1.13.3 Recent developments
    • 14.1.13.4 MnM view
  • 14.1.14 CHEMICEA LIMITED
    • 14.1.14.1 Business overview
    • 14.1.14.2 Products/Solutions/Services offered
    • 14.1.14.3 Recent developments
    • 14.1.14.4 MnM view
  • 14.1.15 KYOWA HAKKO U.S.A., INC.
    • 14.1.15.1 Business overview
    • 14.1.15.2 Products/Solutions/Services offered
    • 14.1.15.3 Recent developments
    • 14.1.15.4 MnM view
• 14.2 DISTRIBUTORS/SUPPLIERS
  • 14.2.1 SEEBIO BIOTECH (SHANGHAI) CO., LTD.
  • 14.2.2 MAGNESIA GMBH
  • 14.2.3 FALCON TRADING INTERNATIONAL
  • 14.2.4 ABCO INDIA
  • 14.2.5 ATLANTIC CHEMICALS TRADING GMBH

15 ADJACENT AND RELATED MARKETS

• 15.1 INTRODUCTION
• 15.2 LIMITATIONS
• 15.3 DIETARY SUPPLEMENTS MARKET
  • 15.3.1 MARKET DEFINITION
  • 15.3.2 MARKET OVERVIEW
• 15.4 VITAMINS MARKET
  • 15.4.1 MARKET DEFINITION
  • 15.4.2 MARKET OVERVIEW

16 APPENDIX

• 16.1 DISCUSSION GUIDE
• 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 16.3 CUSTOMIZATION OPTIONS
• 16.4 RELATED REPORTS
• 16.5 AUTHOR DETAILS